Transcriptional modulation of regulatory T cell development by novel regulators NR4As.
Won HY, Hwang ES
NR4A2 and related proteins help control the development of regulatory T cells, which are essential for preventing immune overreaction. These proteins boost Foxp3, a key gene for regulatory T cells, and may offer new ways to treat immune-related conditions.
- NR4A2 helps boost Foxp3, critical for regulatory T cells
- NR4A2 supports immune balance by promoting Treg development
- NR4A2 may be a target for treating autoimmune or inflammatory diseases
- NR4A2's role is linked to immune regulation, not cancer or neurodevelopment
Efficient induction of neural precursor cells from fibroblasts using stromal cell-derived inducing activity.
Lim MS, Kim SM, Lee EH, Park CH
This study developed a method to efficiently turn skin cells into neural precursor cells and dopamine-producing neurons using special supportive cells and key genes. The technique improves conversion speed and efficiency, which could help model and potentially treat neurological disorders like NR4A2-related syndrome.
- Skin cells were turned into neural precursor cells using supportive stromal cells
- The method boosts efficiency and early expression of neural markers
- Resulting cells can become dopamine neurons using key developmental genes
- This approach may help study and treat NR4A2-related brain disorders
Protective effects of a herbal extract combination of Bupleurum falcatum, Paeonia suffruticosa, and Angelica dahurica against MPTP-induced neurotoxicity via regulation of nuclear receptor-related 1 protein.
Sim Y, Park G, Eo H, Huh E, Gu PS, Hong SP, Pak YK, Oh MS
A combination of three herbal extracts protects dopamine-producing brain cells in a mouse model of Parkinson's disease by boosting levels of the Nurr1 protein, which helps maintain dopamine function and neuron health. This suggests a potential therapeutic approach for conditions involving Nurr1 deficiency, such as NR4A2-related syndrome.
- Herbal extract combo protects dopamine neurons in Parkinson's mice
- Increases Nurr1 protein, critical for dopamine production
- Restores dopamine levels and improves movement
- Activates Nurr1 through signaling pathways in brain cells
- May inform treatments for NR4A2/Nurr1-related disorders
Nurr1 expression is modified by inflammation in microglia.
Lallier SW, Graf AE, Waidyarante GR, Rogers LK
Inflammation and high oxygen levels in newborns can disrupt the brain's Nurr1 protein, which helps control inflammation and protect dopamine neurons. While Nurr1 levels rise in whole brain tissue after exposure, they drop in microglia, suggesting complex regulation that may worsen brain injury in premature infants.
- Nurr1 levels increase in whole brain after inflammation and oxygen exposure
- Nurr1 drops in microglia, the brain's immune cells, under the same conditions
- This mismatch suggests Nurr1 regulation is complex and cell-specific
- Nurr1 may help control brain inflammation, making it a potential treatment target
- Disrupted Nurr1 could contribute to neurological problems in premature babies
Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.
Vidyadhara DJ, Yarreiphang H, Raju TR, Alladi PA
Mice bred from resistant and susceptible strains show strong protection against brain cell damage from MPTP, a toxin that mimics Parkinson's disease, due to greater numbers of dopamine neurons, higher levels of protective proteins like Nurr1, and increased support from growth factors in the brain. This suggests that genetic mixing may boost natural defenses against neurodegeneration.
- Hybrid mice resist MPTP damage better than either parent strain
- More dopamine neurons and higher Nurr1 levels in resistant mice
- Increased brain growth factors may protect neurons
- Genetic mixing may explain lower Parkinson's rates in some mixed-ethnic groups
- Findings suggest protective brain features could be targeted therapeutically
The pharmacological stimulation of Nurr1 improves cognitive functions via enhancement of adult hippocampal neurogenesis.
Kim JI, Jeon SG, Kim KA, Kim YJ, Song EJ, Choi J, Ahn KJ, Kim CJ, Chung HY, Moon M, Chung H
Activating the Nurr1 protein with a drug called amodiaquine boosts the creation of new brain cells in the hippocampus, which improves memory in mice. This suggests that targeting Nurr1 could help treat memory problems in people with NR4A2-related disorders.
- Nurr1 is active in adult brain cells that make new neurons
- A drug that activates Nurr1 increases neuron production
- Activated Nurr1 improves both short- and long-term memory
- This effect happens through key brain signaling pathways
- Nurr1 is a promising target for treating cognitive issues
Opposite effects of acute and chronic amphetamine on Nurr1 and NF-κB p65 in the rat ventral tegmental area.
Arredondo C, González M, Andrés ME, Gysling K
Amphetamine exposure affects Nurr1 and NF-κB p65 in brain dopamine neurons, with acute use boosting these proteins and chronic use reducing them, potentially disrupting dopamine regulation. This suggests inflammation-related pathways may interfere with Nurr1 function, which is critical for dopamine neuron health.
- Acute amphetamine increases Nurr1 and NF-κB p65 in dopamine neurons
- Chronic amphetamine reduces Nurr1 and p65 levels
- NF-κB p65 suppresses Nurr1 activity in dopamine genes
- Nurr1 is essential for dopamine production and neuron survival
- This may explain long-term dopamine dysfunction after drug use
Integrated analysis of DNA methylation and RNA‑sequencing data in Down syndrome.
Zhang J, Zhou W, Liu Y, Li N
This study found that genes on chromosome 21, including RUNX1, NR4A2, EGR2, EGR3, and ID4, show abnormal DNA methylation and gene expression in Down syndrome, suggesting they play key roles in the condition's development. These genes are linked to brain development and function, with NR4A2 and EGR2/3 forming protein interaction networks that may influence neurological symptoms.
- NR4A2 is part of a network linked to Down syndrome brain changes
- Abnormal methylation affects genes on chromosome 21
- RUNX1, ID4, and EGR2/3 are involved in brain development
- These genes may contribute to intellectual and neurological features
- Protein interactions suggest potential therapeutic targets
Adenovirus-mediated expression of orphan nuclear receptor NR4A2 targeting hepatic stellate cell attenuates liver fibrosis in rats.
Chen P, Li J, Huo Y, Lu J, Wan L, Yang Q, Huang J, Gan R, Guo C
Boosting NR4A2 levels in liver cells reduces scarring in rats by calming down the overactive cells that produce scar tissue. This suggests NR4A2 could be a promising target for treating liver fibrosis.
- NR4A2 reduces scar tissue production in liver cells
- Increasing NR4A2 calms down harmful liver cell activation
- NR4A2 therapy improved liver fibrosis in rat models
- NR4A2 may be a viable target for anti-fibrotic treatments
BMP2 promotes the differentiation of neural stem cells into dopaminergic neurons in vitro via miR-145-mediated upregulation of Nurr1 expression.
Yan W, Chen ZY, Chen JQ, Chen HM
BMP2 helps neural stem cells turn into dopamine-producing neurons in the lab, partly by reducing a molecule called miR-145, which normally blocks Nurr1, a key protein for dopamine neuron development. Boosting Nurr1 can overcome the roadblock caused by high miR-145 levels.
- BMP2 drives neural stem cells to become dopamine neurons
- miR-145 blocks Nurr1 and slows neuron development
- BMP2 lowers miR-145, freeing up Nurr1 to work
- Nurr1 is essential for BMP2’s effect on neuron formation
- Targeting miR-145 or boosting Nurr1 may help treat NR4A2-related conditions
Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families.
Leppa VM, Kravitz SN, Martin CL, Andrieux J, Le Caignec C, Martin-Coignard D, DyBuncio C, Sanders SJ, Lowe JK, Cantor RM, Geschwind DH
This study found that rare inherited and new genetic changes (CNVs) contribute to autism risk in families with multiple affected children, including a newly identified risk region on chromosome 2q24 involving the NR4A2 gene, which is linked to brain development and function. The genetic patterns in these families are complex, with not all affected siblings sharing the same CNV, suggesting additional genetic or environmental factors are involved.
- NR4A2 is implicated in a new autism risk region on chromosome 2q24
- Inherited CNVs play a significant role in multiplex autism families
- Not all affected siblings share the same risk CNV, indicating multiple factors
- Genetic architecture in multiplex families is more complex than in simplex families
- Findings support the need for deeper genetic testing in large autism families
Nurr1 promotes intestinal regeneration after ischemia/reperfusion injury by inhibiting the expression of p21 (Waf1/Cip1).
Zu G, Yao J, Ji A, Ning S, Luo F, Li Z, Feng D, Rui Y, Li Y, Wang G, Tian X
Nurr1 helps the intestine heal after injury by turning off a gene called p21 that stops cell growth, allowing intestinal cells to multiply and repair damage. This process happens without involving the p53 protein, which is often linked to cancer and cell death.
- Nurr1 boosts intestinal cell growth after injury
- Nurr1 turns off p21 to allow cell division
- This action happens directly at the gene level
- The process does not require p53
- Nurr1 is naturally activated during healing
Paternal chronic colitis causes epigenetic inheritance of susceptibility to colitis.
Tschurtschenthaler M, Kachroo P, Heinsen FA, Adolph TE, Rühlemann MC, Klughammer J, Offner FA, Ammerpohl O, Krueger F, Smallwood S, Szymczak S, Kaser A, Franke A
Father mice with colitis pass on increased risk for colitis to their offspring through epigenetic changes in sperm, including altered methylation of the Nr4a2 gene, which is linked to metabolism and inflammation. These changes are associated with lower birth weight and greater colitis severity in the next generation.
- Father's colitis increases offspring colitis risk
- Epigenetic changes in sperm affect gene expression
- Nr4a2 gene methylation altered in offspring
- Offspring show metabolic and inflammatory changes
- Changes passed through sperm, not just genes
Re-Cloning the N27 Dopamine Cell Line to Improve a Cell Culture Model of Parkinson's Disease.
Gao L, Zhou W, Symmes B, Freed CR
The new N27-A cell line is a more consistent and accurate model of dopamine-producing neurons than the old N27 line, with higher levels of key dopamine markers and improved sensitivity to Parkinson's-related toxins, making it better for studying disease mechanisms and testing potential treatments.
- N27-A cells are nearly 100% pure dopamine neurons
- They express high levels of TH, DAT, and Nurr1
- They respond better to Parkinson's toxins like MPP+
- They release dopamine naturally, mimicking real neurons
- The line is more reliable for drug and toxicity testing
Effects of Simazine Exposure on Neuronal Development-Related Factors in MN9D Cells.
Yu J, Li X, Yang J, Wu Y, Li B
Simazine, a common herbicide, disrupts key genes involved in dopamine neuron development in lab-grown brain cells. It alters the activity of Nurr1 and other critical factors, potentially affecting brain development through multiple interconnected pathways.
- Simazine affects genes crucial for dopamine neuron formation
- Nurr1 levels change in a dose-dependent way
- Two major pathways linked to neuron development are disrupted
- Higher simazine doses increase key proteins like TH and Nurr1
- Exposure may impact early brain development through multiple gene networks
Nurr1 and PPARγ protect PC12 cells against MPP(+) toxicity: involvement of selective genes, anti-inflammatory, ROS generation, and antimitochondrial impairment.
Jodeiri Farshbaf M, Forouzanfar M, Ghaedi K, Kiani-Esfahani A, Peymani M, Shoaraye Nejati A, Izadi T, Karbalaie K, Noorbakhshnia M, Rahgozar S, Baharvand H, Nasr-Esfahani MH
Activating Nurr1 and PPARγ protects nerve cells from damage caused by a toxin that mimics Parkinson's disease, reducing harmful molecules, preserving energy-producing parts of cells, and improving cell survival.
- Nurr1 and PPARγ activation protect nerve cells from toxin damage
- Reduced harmful molecules and improved cell energy function
- Combined treatment worked better than either alone
- These pathways may help protect dopamine-producing neurons
- Findings support testing these targets for NR4A2-related conditions
Molecular characterization and analysis of the porcine NURR1 gene.
Larsen K, Momeni J, Farajzadeh L, Callesen H, Bendixen C
This study identifies and analyzes the NURR1 gene in pigs, finding it highly similar to human NURR1 and showing that its activity is regulated by DNA methylation during brain development. The gene is active early in fetal development and its expression changes in key brain regions, suggesting methylation plays a role in turning the gene on or off at critical times.
- Pig NURR1 is nearly identical to human NURR1
- NURR1 is active early in brain development
- DNA methylation decreases in the promoter during development, increasing gene activity
- Methylation levels in brain tissue are high, but low in the promoter region
- Changes in methylation correlate with changes in NURR1 expression
Directed differentiation of postnatal hippocampal neural stem cells generates nuclear receptor related‑1 protein‑ and tyrosine hydroxylase‑expressing cells.
Ding Y, Zhang Z, Ma J, Xia H, Wang Y, Liu Y, Ma Q, Sun T, Liu J
Postnatal hippocampal neural stem cells can be guided in the lab to become neurons that produce Nurr1 and tyrosine hydroxylase, proteins critical for dopamine-producing brain cells. This suggests a potential source of replacement neurons for treating Parkinson’s disease.
- Hippocampal stem cells can become dopamine neuron-like cells
- Nurr1 and TH expression increases with directed differentiation
- These cells may help repair brain circuits lost in Parkinson’s
- Lab-grown neurons could support future cell therapies
Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
Gorelenkova Miller O, Behring JB, Siedlak SL, Jiang S, Matsui R, Bachschmid MM, Zhu X, Mieyal JJ
Increased levels of glutaredoxin-1 (Grx1) in the brain promote harmful inflammation in immune cells called microglia, leading to the death of dopamine-producing neurons, which are critical in Parkinson’s disease. This process is linked to earlier disease onset and may be influenced by genetic and metabolic factors like diabetes.
- Grx1 upregulation triggers brain inflammation and neuron death
- High Grx1 levels correlate with earlier Parkinson’s onset
- Grx1 drives microglial activation via the Nurr1/NF-κB pathway
- Blocking Grx1 protects dopamine neurons in mouse models
- Metabolic conditions like diabetes may worsen Grx1-related damage
Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells.
Grow DA, Simmons DV, Gomez JA, Wanat MJ, McCarrey JR, Paladini CA, Navara CS
This study successfully created dopamine-producing neurons from baboon stem cells that closely match human midbrain neurons in function and gene expression, offering a highly relevant animal model for testing stem cell therapies for Parkinson's disease and other neurodegenerative conditions.
- Baboon stem cells became functional dopamine neurons
- Neurons matched human midbrain cells in key genes and activity
- Model can test safety and effectiveness of stem cell treatments
- Baboons are ideal due to brain and immune system similarity to humans
- Neurons released dopamine when stimulated, showing real function
Active coping of prenatally stressed rats in the forced swimming test: involvement of the Nurr1 gene.
Montes P, Ruiz-Sánchez E, Calvillo M, Rojas P
Prenatal stress in rats leads to changes in the Nurr1 gene that help offspring cope better with stress in adulthood, suggesting a protective role for Nurr1 in building resilience. Lower Nurr1 levels in the hippocampus were linked to depressive-like behavior, but prenatally stressed rats maintained Nurr1 and related genes, which correlated with active coping in stress tests.
- Prenatal stress may boost resilience via Nurr1 in the brain
- Low Nurr1 in adults leads to depressive-like behavior
- Stressed rats maintained Nurr1 and BDNF levels
- Nurr1 helps regulate stress response and coping
- Findings suggest Nurr1 as a potential therapeutic target
Nuclear receptor expression atlas in BMDCs: Nr4a2 restricts immunogenicity of BMDCs and impedes EAE.
Saini A, Mahajan S, Gupta P
Nr4a2 helps keep immune cells called dendritic cells from becoming overactive, reducing inflammation and protecting against autoimmune disease in mice. This suggests Nr4a2 could be a target for treating immune-related conditions, including those affecting the brain.
- Nr4a2 reduces immune activation in dendritic cells
- It promotes a calming, tolerogenic state in immune cells
- It protects against autoimmune brain inflammation in mice
- Nr4a2 boosts regulatory T cells and reduces harmful immune responses
Effect of spontaneous term labour on the expression of the NR4A receptors nuclear receptor related 1 protein (Nurr1), neuron-derived clone 77 (Nur77) and neuron-derived orphan receptor 1 (NOR1) in human fetal membranes and myometrium.
Lappas M
Spontaneous labor in humans increases levels of NR4A receptors Nurr1 and Nur77 in fetal membranes and uterine muscle, and bacterial triggers can further boost these receptors, which may drive inflammation and labor-related processes like membrane rupture and contractions.
- Labor increases Nurr1 and Nur77 in birth tissues
- Bacterial signals boost NR4A receptors in fetal membranes and uterus
- NR4A receptors may promote labor through inflammation
- These receptors are linked to key labor events like membrane rupture
- Findings suggest NR4A pathways could be targeted to manage labor
Induction of specific neuron types by overexpression of single transcription factors.
Teratani-Ota Y, Yamamizu K, Piao Y, Sharova L, Amano M, Yu H, Schlessinger D, Ko MS, Sharov AA
Overexpressing certain transcription factors can directly turn stem cells into specific types of neurons, including GABAergic, dopaminergic, and cholinergic neurons, with some methods producing nearly pure populations of the desired cell type.
- Single transcription factors can guide stem cells into specific neuron types.
- Nr4a2 induces dopaminergic neurons, relevant to NR4A2-related syndrome.
- Results show high purity and correct marker expression for target neurons.
- This approach may help model and treat neurological conditions like NR4A2 syndrome.
- Findings support using transcription factor overexpression for cell-based therapies.
Daphnane Diterpenes from Daphne genkwa Activate Nurr1 and Have a Neuroprotective Effect in an Animal Model of Parkinson's Disease.
Han BS, Kim KS, Kim YJ, Jung HY, Kang YM, Lee KS, Sohn MJ, Kim CH, Kim KS, Kim WG
Two natural compounds from Daphne genkwa, genkwanine N and yuanhuacin, activate Nurr1, a key protein for dopamine neuron health, and protect brain cells in a Parkinson's disease model. These compounds reduced neuron death and brain inflammation, improved movement symptoms, and preserved dopamine-producing neurons in rats. They are the first natural Nurr1 activators identified and may lead to new Parkinson's treatments.
- Genkwanine N and yuanhuacin activate Nurr1
- They protect dopamine neurons in Parkinson's models
- They reduce brain inflammation and improve movement
- These are the first natural Nurr1-activating compounds
- Potential for new Parkinson's disease treatments
Using iPSC-derived human DA neurons from opioid-dependent subjects to study dopamine dynamics.
Sheng Y, Filichia E, Shick E, Preston KL, Phillips KA, Cooperman L, Lin Z, Tesar P, Hoffer B, Luo Y
Human stem cell-derived dopamine neurons from people with opioid dependence show that a genetic variation in the dopamine transporter gene affects dopamine system function, and the drug valproic acid changes key genes involved in dopamine regulation, including Nurr1, which is relevant to NR4A2-related syndrome.
- Genetic variation in dopamine transporter affects neuron function
- Valproic acid alters Nurr1, TH, and dopamine receptor levels
- Stem cell models reveal gene-drug interactions in dopamine neurons
- Findings may inform treatments for dopamine-related disorders
Developmental gene expression in the mouse clarifies the organization of the claustrum and related endopiriform nuclei.
Watson C, Puelles L
The claustrum and related brain regions develop from specific areas in the fetal mouse brain, with a key gene called Nr4a2 marking cells that form the claustrum and the dorsal endopiriform nucleus. These cells originate in the lateral brain wall and migrate to their final positions during early development. The findings help explain how brain circuits form and may relate to human conditions involving NR4A2 gene mutations.
- NR4A2 gene marks cells that form the claustrum and dorsal endopiriform nucleus
- These cells develop in the lateral brain wall and migrate to their final positions
- The claustrum has deep and superficial layers with distinct origins
- Dorsal and ventral endopiriform nuclei develop from different brain regions
- NR4A2 is critical in organizing early brain circuit formation
Efficient generation of dopaminergic-like neurons by overexpression of Nurr1 and Pitx3 in mouse induced Pluripotent Stem Cells.
Salemi S, Baktash P, Rajaei B, Noori M, Amini H, Shamsara M, Massumi M
Overexpressing the Nurr1 and Pitx3 genes in mouse stem cells efficiently turns them into dopamine-producing neurons, which could help develop cell therapies for Parkinson's disease.
- Nurr1 and Pitx3 drive stem cells to become dopamine neurons
- Generated neurons make and release dopamine when stimulated
- This method creates functional dopamine neurons in a lab setting
- Potential for future Parkinson's cell therapies
Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.
Montarolo F, Perga S, Martire S, Navone DN, Marchet A, Leotta D, Bertolotto A
People with Parkinson's disease have lower levels of NR4A1, NR4A2, and NR4A3 genes in their blood, suggesting these genes may play a broader role in the disease than just NR4A2 alone. In Alzheimer's disease, only NR4A1 levels were reduced, indicating a different pattern of gene changes.
- NR4A subfamily genes are lower in Parkinson’s blood
- NR4A2 is not the only affected gene in Parkinson’s
- Only NR4A1 is reduced in Alzheimer’s disease
- These genes may be involved in disease processes beyond the brain
- Could help guide future Parkinson’s treatments
In situ hybridization analyses of claustrum-enriched genes in marmosets.
Watakabe A
The claustrum, a brain region linked to sensory integration and consciousness, relies on a specific set of genes for its function. In marmosets, genes like NR4A2 (nurr1) and others are highly active in the claustrum and related areas, showing patterns similar to those in macaques and mice, suggesting shared brain organization across primates.
- NR4A2 (nurr1) is highly expressed in the claustrum and cortex in marmosets
- Claustrum gene patterns are similar across primates, including macaques and marmosets
- Some genes show species-specific differences in cortical expression
- The claustrum's gene set is evolutionarily conserved
- Findings may inform understanding of NR4A2-related brain development
Identification of a Binding Site for Unsaturated Fatty Acids in the Orphan Nuclear Receptor Nurr1.
de Vera IM, Giri PK, Munoz-Tello P, Brust R, Fuhrmann J, Matta-Camacho E, Shang J, Campbell S, Wilson HD, Granados J, Gardner WJ, Creamer TP, Solt LA, Kojetin DJ
Unsaturated fatty acids like DHA bind directly to the Nurr1 protein, changing how it functions in cells and potentially affecting its ability to regulate genes. This is the first evidence that a natural molecule can bind to Nurr1's active site and influence its activity.
- DHA and other unsaturated fats bind to Nurr1
- Binding changes how Nurr1 interacts with other proteins
- This affects Nurr1's ability to turn on genes
- The binding site is in the protein's ligand pocket
- Findings suggest dietary fats may influence Nurr1 function
Erratum for the Research Article: "α-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons" by M. Decressac, B. Kadkhodaei, B. Mattsson, A. Laguna, T. Perlmann, A. Björklund.
Mutations in the NR4A2 gene disrupt the function of the NURR1 protein, which is essential for the development and survival of dopamine neurons. This leads to impaired signaling of GDNF, a key factor that supports these neurons, contributing to the neurological symptoms seen in NR4A2-related syndrome.
- NR4A2 mutations impair NURR1 function
- NURR1 is vital for dopamine neuron health
- GDNF signaling is disrupted in affected neurons
- This mechanism may explain core symptoms
- Potential target for future therapies
Dopaminergic Neuronal Differentiation from the Forebrain-Derived Human Neural Stem Cells Induced in Cultures by Using a Combination of BMP-7 and Pramipexole with Growth Factors.
Yang H, Wang J, Wang F, Liu X, Chen H, Duan W, Qu T
This study shows that a combination of pramipexole, BMP-7, and growth factors can efficiently turn human forebrain neural stem cells into dopamine-releasing neurons, which may help treat Parkinson’s disease. The resulting neurons produce and release dopamine, a key function for replacing lost brain cells.
- Pramipexole and BMP-7 boost dopamine neuron formation
- Over 25% of cells became dopamine-producing neurons
- Neurons released dopamine under both resting and stimulated conditions
- Protocol improves dopamine output compared to controls
- Potential for future cell-based therapies in dopamine disorders
Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction.
Zhang L, Cen L, Qu S, Wei L, Mo M, Feng J, Sun C, Xiao Y, Luo Q, Li S, Yang X, Xu P
Activating the Wnt/β-catenin pathway protects dopamine-producing cells from damage by boosting Nurr1, a key protein linked to Parkinson’s disease. This suggests a potential treatment strategy that could help preserve brain cells in conditions like NR4A2-related syndrome.
- Boosting β-catenin protects brain cells from toxin damage
- Nurr1 levels rise when β-catenin is activated
- The two proteins work together to support neuron survival
- This pathway may offer a treatment target for NR4A2-related disorders
Nurr1-Based Therapies for Parkinson's Disease.
Dong J, Li S, Mo JL, Cai HB, Le WD
Nurr1 (NR4A2) is a key protein for the development and survival of dopamine neurons, and its dysfunction is linked to Parkinson's disease. Boosting Nurr1 activity through drugs or gene therapy protects these neurons and improves dopamine function in animal models, suggesting a promising new treatment approach.
- Nurr1 supports dopamine neuron health and survival
- Activating Nurr1 protects neurons from damage
- Nurr1 therapies improve dopamine function in models
- Combining Nurr1 treatments with other pathways may boost effects
- This approach is being developed as a next-generation Parkinson's therapy